Trial Profile
A Multi-Center, Randomized, Single-Blind, Parallel Group Study to Compare the Efficacy, Tolerability and Safety, of Copaxone to That of High Dose Interferon (Betaseron or Rebif) in the Treatment of Relapsing Multiple Sclerosis Patients
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2021
Price :
$35
*
At a glance
- Drugs Glatiramer acetate (Primary) ; Interferon beta-1a; Interferon beta-1b
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Teva Pharmaceutical Industries
- 09 Nov 2008 'Teva Pharmaceutical Industries' added as reported by ClinicalTrials.gov.
- 09 Nov 2008 Actual patient number (91) added as reported by ClinicalTrials.gov.
- 09 Nov 2008 Status changed from completed to discontinued as reported by ClinicalTrials.gov.